Neutralizing antibodies against HIV determined by amplification of viral long terminal repeat sequences from cells infected in vitro by nonneutralized virions

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 1, 1998, Pages 27-34

  Yang, Gang ^a   D'Souza, M Patricia ^b   Vyas, Girish N ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV 1; HIV neutralizing antibodies; Laboratory assays; PCR; Vaccines

Indexed keywords

ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS DNA;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOASSAY; LONG TERMINAL REPEAT; LYMPHOID CELL; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031974558     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199801010-00004     Document Type: Article

References (27)

1. Conley AJ, Kessler JA, Boots LJ, et al. The consequence of passive administration of anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate. J Virol 1996;70:6751-8.
2. Gauduin MC, Safrit JT, Weir R, et al. Pre- and postexposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody. J Infect Dis 199;171:1203-9.
3. Girard M, Meignier B, Barre-Sinoussi F, et al. Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. J Virol 1995;69:6239-48.
4. Zolla-Pazner S, Alving C, Belshe R, et al. Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines. J Infect Dis 1997;175:764-74.
5. Montefiori DD, Pantaleo G, Fink LM, et al. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressor. J Infect Dis 1996;173: 60-7.
6. Hansen CV. Measuring vaccine-induced HIV neutralization: Report of a workshop. AIDS Res Hum Retroviruses 1994;10:645-8.
7. Golding H, D'Souza MP, Bradac J, Mathieson B, Fast P. Neutralization of HIV-1. AIDS Res Hum Retroviruses 1994;10:633-43.
8. D'Souza MP, Milman G, Bradacn JA, McPhee D, Hanson CV, Hendry RM, collaborating investigators. Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies. AIDS 1995;9:867-74.
9. Trkola A, Pomales AB, Yuan H, et al. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virol 1995; 69:6609-18.
10. Robb ML, Polonis V, Vahey M, et al. HIV neutralization assay using polymerase chain reaction derived molecular signals. J Acquir Immune Defic Syndr Hum Retrovirol 1992;5:1224-9.
11. D'Souza MP, Livnat D, Bradac JA, et al. Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: Performance criteria for selecting candidate antibodies for clinical trials. J Infect Dis 1997;175:1056-62.
12. Haseltine WA. Molecular biology of the human immunodeficiency virus type 1. FASEB J 1991;5:2352.
13. Yang G, Garhwal S, Olson JC, Vyas GN. Flow cytometric immunodetection of human immunodeficiency virus type 1 proviral DNA by heminested PCR and digoxigenin-labeled probes. Clin Diag Lab Immunol 1994;1:26-31.
14. Trono D. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J Virol 1992;66:4893-900.
15. Zhang H, Dornadula G, Pomerantz RJ. Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenvironments: an important stage for viral infection of non-dividing cells. J Virol 1996;70:2809-24.
16. Hollinger FB, Bremer JW, Myers LE, Gold JWM, McQuay L, the NIH/NIAID/NAIDS/ACTG virology laboratories. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS clinical group. J Clin Microbiol 1992;30:1787-94.
17. Johnson VA, Byingto RE. Infectivity assay. In Aldovini A, Walker BD, eds. Techniques in HIV research. New York: Stockton Press, 1990:71-76.
18. Ulrich PP, Romeo JM, Daniel LJ, Vyas GN. An improved method for the detection of hepatitis C virus RNA in plasma utilizing heminested primers and internal control RNA. PCR Methods Appl 1993;2:241-9.
19. Myers M, Korber B, Wain-Hobson S, Smith SF, Pavlakis GN. Human retroviruses and AIDS: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos: Los Alamos National Laboratory, 1993.
20. Yang G, Olson JC, Pu R, Vyas GN. Flow cytometric detection of human immunodeficiency virus type 1 proviral DNA by the polymerase chain reaction incorporating digoxigenin- or fluorescein-labeled dUTP. Cytometry 1995;21:197-202.
21. Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 1990;9:1551-60.
22. Hewlett IK, Geyer SJ, Hawthorn CA, Ruta M, Epstain JS. Kinetics of early HIV-1 gene expression in infected H9 cells assessed by PCR. Oncogene 1991;6:491-3.
23. Bourinbaior AS. The ratio of defective HIV-1 particles to replication-competent infectious virions. Acta Virol (Praha) 1994;38:59-61.
24. Dorenbaum A, Venkateswaran KS, Yang G, Comeau AM, Wara D, Vyas GN. Transmission of HIV-1 in infants born to seropositive mothers: PCR-amplified proviral DNA detected by flow cytometric analysis of immunoreactive beads. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:35-42.
25. Burns DPW, Desrosiers RC. A caution on the use of SIV/HIV gag antigen detection system in neutralization assays. AIDS Res Hum Retroviruses 1992;8:1189-92.
26. Mascola JR, Burke DS. Antigen detection in neutralization assays: high levels of interfering anti-p24 antibodies in some plasma. AIDS Res Hum Retroviruses 1993;9:1173-4.
27. Sano K, Lee MH, Morales F, et al. Antibody that inhibits human immunodeficiency virus reverse transcriptase and association with inability to isolate virus. J Clin Microbiol 1987;25:2415-17.